Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation ...

Medtech startup Axio Biosolutions has raised $5.2 Mn (INR 36 Cr) in Series B-1 round led by Omidyar Network India. Axio’s existing investors Accel, University of California, Ratan Tata-backed ...

Axio BioPharma and Likarda Announce Strategic Partnership to Accelerate Biologic Drug Development and Delivery PR Newswire MADISON, Wis. and KANSAS CITY, Mo., June 9, 2025 ...

Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation technologies, ...

Partnership combines AI-powered protein manufacturing with advanced drug delivery technologies to accelerate timelines and improve therapeutic outcomes. MADISON, WI and KANSAS CITY, MO, June 9, 2025 - ...